Interleukin-1- and Type I Interferon-Dependent Enhanced Immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef Vaccine Vector with Dual Deletions of Type I and Type II Interferon-Binding Proteins
暂无分享,去创建一个
G. Pantaleo | R. Sékaly | A. Harari | M. Cameron | T. Calandra | T. Roger | E. Haddad | M. Esteban | B. Perdiguero | J. Delaloye | C. E. Gómez | A. Filali‐Mouhim | Jean-Pierre Goulet